RAPIDITY OF SYMPTOM IMPROVEMENTS DURING FILGOTINIB INDUCTION THERAPY IN PATIENTS WITH ULCERATIVE COLITIS: POST HOC ANALYSIS OF THE PHASE 2B/3 SELECTION STUDY

Silvio Danese  ¹     Toshifumi Hibi  ²     Jeremy Hsieh  ³     Chohee Yun  ³     Jie Zhang  ³     Sally Zhao  ³     Edward V Loftus Jr  ⁴     Gerhard Rogler  ⁵     Timothy Ritter  ⁶     Jason Dinoso  ^6    
1 Humanitas Clinical and Research Center, IRCCS and Humanitas University, Milan, Italy
² Kitasato Institute Hospital, Kitasato University, Tokyo, Japan
³ Gilead Sciences, Inc., Foster City, CA, United States
⁴ Mayo Clinic College of Medicine, Rochester, MN, United States
⁵ University Hospital of Zurich, University of Zurich, Zurich, Switzerland
⁶ GI Alliance, Southlake, TX, United States

Topic
IBD

Session
IBD drug efficacy and safety

Conference
UEG Week Virtual 2021

Citation
United European Gastroenterology Journal 2021; 9 (Supplement 8)